Dana K. Andersen

3.6k total citations · 1 hit paper
52 papers, 2.8k citations indexed

About

Dana K. Andersen is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Dana K. Andersen has authored 52 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 37 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Genetics. Recurrent topics in Dana K. Andersen's work include Diabetes Treatment and Management (29 papers), Pancreatic function and diabetes (24 papers) and Pancreatitis Pathology and Treatment (13 papers). Dana K. Andersen is often cited by papers focused on Diabetes Treatment and Management (29 papers), Pancreatic function and diabetes (24 papers) and Pancreatitis Pathology and Treatment (13 papers). Dana K. Andersen collaborates with scholars based in United States, Canada and United Kingdom. Dana K. Andersen's co-authors include Dariush Elahi, Lori A. Slezak, Douglas L. Rothman, Kitt Falk Petersen, Gary W. Cline, Gerald I. Shulman, Margaret E. Griffin, Ripudaman S. Hundal, Sylvie Dufour and Didier Laurent and has published in prestigious journals such as Journal of Clinical Investigation, Gastroenterology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Dana K. Andersen

50 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of free fatty acids on glucose transport and IRS-1–associated phosphatidylinositol 3-kinase activity

1999 974 citations Dana K. Andersen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dana K. Andersen United States	23	1.3k	1.2k	830	781	438	52	2.8k
Roberto Torella Italy	30	1.1k 0.8×	633 0.5×	637 0.8×	400 0.5×	1.0k 2.3×	135	3.1k
Takeshi Kurose Japan	27	1.2k 0.9×	685 0.6×	801 1.0×	374 0.5×	204 0.5×	76	2.1k
Edward C. Mun United States	20	785 0.6×	1.5k 1.3×	1.5k 1.8×	2.1k 2.8×	586 1.3×	33	3.7k
F. P. Alford Australia	36	2.0k 1.5×	722 0.6×	700 0.8×	1.0k 1.3×	549 1.3×	118	3.5k
Ronald L. Prigeon United States	32	2.8k 2.2×	2.3k 1.9×	1.3k 1.6×	1.4k 1.8×	623 1.4×	43	5.0k
Giuseppe Daniele Italy	26	1.6k 1.2×	986 0.8×	1.1k 1.3×	496 0.6×	365 0.8×	63	2.7k
D.W. Erkelens Netherlands	25	1.1k 0.8×	531 0.4×	382 0.5×	497 0.6×	221 0.5×	59	2.2k
L. Groop Sweden	30	1.3k 1.0×	873 0.7×	1.1k 1.4×	1.1k 1.5×	499 1.1×	57	3.5k
Emmanuel Disse France	28	560 0.4×	1.1k 0.9×	527 0.6×	934 1.2×	522 1.2×	92	2.8k
Steven C. Griffen United States	28	1.8k 1.4×	1.1k 0.9×	888 1.1×	707 0.9×	639 1.5×	42	3.0k

Countries citing papers authored by Dana K. Andersen

Since Specialization

Citations

This map shows the geographic impact of Dana K. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dana K. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dana K. Andersen more than expected).

Fields of papers citing papers by Dana K. Andersen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dana K. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dana K. Andersen. The network helps show where Dana K. Andersen may publish in the future.

Co-authorship network of co-authors of Dana K. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Dana K. Andersen. A scholar is included among the top collaborators of Dana K. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dana K. Andersen. Dana K. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Andersen, Dana K.. (2012). How Can Educators Use Simulation Applications to Teach and Assess Surgical Judgment?. Academic Medicine. 87(7). 934–941. 53 indexed citations

Rabiee, Atoosa, J. Trent Magruder, Olga D. Carlson, et al.. (2010). Hyperinsulinemic Hypoglycemia After Roux-en-Y Gastric Bypass: Unraveling the Role of Gut Hormonal and Pancreatic Endocrine Dysfunction. Journal of Surgical Research. 167(2). 199–205. 62 indexed citations

Rabiee, Atoosa, Andrew Dwyer, Frances J. Hayes, et al.. (2010). Impact of Acute Biochemical Castration on Insulin Sensitivity in Healthy Adult Men. Endocrine Research. 35(2). 71–84. 15 indexed citations

Rabiee, Atoosa, Lisa A. Eaton, Rania Abu‐Hamdah, et al.. (2009). Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit. Surgery. 146(5). 922–930. 18 indexed citations

Rabiee, Atoosa, et al.. (2009). Numerical and Clinical Accuracy of a Continuous Glucose Monitoring System during Intravenous Insulin Therapy in the Surgical and Burn Intensive Care Units. Journal of Diabetes Science and Technology. 3(4). 951–959. 56 indexed citations

Elahi, Dariush, Josephine M. Egan, Richard P. Shannon, et al.. (2008). GLP‐1 (9–36) Amide, Cleavage Product of GLP‐1 (7–36) Amide, Is a Glucoregulatory Peptide. Obesity. 16(7). 1501–1509. 74 indexed citations

Andersen, Dana K.. (2007). Mechanisms and Emerging Treatments of the Metabolic Complications of Chronic Pancreatitis. Pancreas. 35(1). 1–15. 47 indexed citations

Brunicardi, F. Charles, Rochelle L Chaiken, Alice S. Ryan, et al.. (1996). Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis.. The Journal of Clinical Endocrinology & Metabolism. 81(10). 3566–3572. 73 indexed citations

Brunicardi, F. Charles, David M. Shavelle, & Dana K. Andersen. (1995). Neural regulation of the endocrine pancreas. International Journal of Pancreatology. 18(3). 177–195. 77 indexed citations

10.

Stathopoulos, George, et al.. (1995). Rapidly Progressive Sclerosing Cholangitis Following Surgical Treatment of Pancreatic Pseudotumor. Journal of Clinical Gastroenterology. 21(2). 143–148. 13 indexed citations

11.

Andersen, Dana K., et al.. (1994). Gastrointestinal hormones in disease. 11(1). 21–52. 1 indexed citations

12.

Andersen, Dana K., et al.. (1994). Insulin Regulation of Hepatic Glucose Transporter Protein Is Impaired in Chronic Pancreatitis. Annals of Surgery. 219(6). 679–687. 18 indexed citations

13.

Elahi, Dariush, Barbara A. Clark, Barbara B. Kahn, et al.. (1993). Sequential evaluation of islet cell responses to glucose in the transplanted pancreas in humans. The American Journal of Surgery. 165(1). 15–22. 13 indexed citations

14.

Andersen, Dana K., et al.. (1993). Surgery in the elderly: Observations on the pathophysiology and treatment of cholelithiasis. Experimental Gerontology. 28(4-5). 459–472. 16 indexed citations

15.

Goldstein, Jeffrey A., et al.. (1989). Reversal of in vitro hepatic insulin resistance in chronic pancreatitis by pancreatic polypeptide in the rat.. PubMed. 106(6). 1128–32; discussion 1132. 14 indexed citations

16.

Andersen, Dana K., et al.. (1986). Gastric inhibitory polypeptide enhancement of insulin action of hepatic glucose production in vitro. 37. 118–121. 2 indexed citations

17.

Goulet, Robert J., et al.. (1984). Multiple Pancreatic Pseudocyst Disease. Annals of Surgery. 199(1). 6–13. 28 indexed citations

18.

Elahi, Dariush, et al.. (1984). The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus. Diabetes. 33(10). 950–957. 25 indexed citations

19.

Andersen, Dana K., et al.. (1982). The effect of gip on splanchnic and systemic blood flow. Gastroenterology. 82. 1 indexed citations

20.

Hanks, John B., William C. Meyers, & Dana K. Andersen. (1979). The effects of gastric inhibitory polypeptide (GIP) on hepatic glucose production. Gastroenterology. 76. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact